{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:19:56Z","timestamp":1793837996735,"version":"4.6.1"},"reference-count":56,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:sec id=\"ab-noi260006-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Psychiatric disturbances are common in epilepsy and are associated with increased risk of premature mortality, lower quality of life, and poor response to antiseizure medications (ASMs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260006-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the role of psychiatric disturbances at the time of epilepsy diagnosis in predicting risk of future treatment resistance in focal epilepsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260006-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>The Human Epilepsy Project (HEP) is a prospective, observational, international, and multicenter cohort study with follow-up for up to 6 years. Participants with newly diagnosed focal epilepsy, enrolled within 4 months of initiating ASM treatment, between the ages 18 and 60 years, and without significant other comorbidities were recruited during the open period of 2012 to 2020. Data analysis was performed from January to September 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260006-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Presence of a psychiatric diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260006-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Presence of psychiatric diagnosis (mood\/anxiety disorders) measured by Mini International Neuropsychiatric Interview (MINI) and\/or suicidality measured by Columbia-Suicide Severity Rating Scale (C-SSRS) at enrollment. Treatment response included the following outcomes: treatment resistant (TR), defined as failure of first 2 adequate ASM trials (ongoing seizures at\/above therapeutic doses); treatment sensitive (TS), defined by a minimum period of seizure freedom on first 2 adequate ASM trials (12 months\/3-fold greatest pretreatment seizure-free interval, whichever is longer); and indeterminate (neither TR\/TS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260006-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 376 enrolled adults, 347 (median [IQR] age at seizure onset, 33 [23-44] years; 209 female [60.2%]) completed the MINI and C-SSRS at enrollment. Of these individuals, 191 (55%) were TS, 83 (24%) TR, and 73 (21%) indeterminate. The rate of psychiatric disturbance (mood\/anxiety disorder; suicidality) at epilepsy diagnosis was 38% (n\u2009=\u2009133). Fifty-seven (16%) had mood\/anxiety disorder(s) without suicidality, and 75 (22%) expressed suicidality with or without a psychiatric disorder. Suicidality at epilepsy diagnosis was associated with greater than 2-fold risk of developing TR (relative risk [RR],\u20092.02; 95% CI, 1.32-3.09;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.001). There were no significant overall associations between mood\/anxiety disorders and TR. Suicidality alone significantly increased TR probability from 16.3% (95% CI, 11.3%-21.3%) in those with no psychiatric disturbance to 47.1% (RR,\u20092.89; 95% CI, 1.65-5.05;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Anxiety disorder alone increased TR probability to 32.9% (RR,\u20092.02; 95% CI, 1.10-3.71;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.02), although this was not statistically significant after correcting for multiple comparisons. There was no significant change in TR probability when mood disorder alone was present; however, presence of mood disorder with suicidality increased TR probability to 39.6% (RR,\u20092.43; 95% CI, 1.26-4.68;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.008).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260006-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Results of this cohort study reveal that suicidality at the time of focal epilepsy diagnosis was associated with future drug resistance and may be a marker of more severe neuropathology. Psychiatric screening at time of diagnosis may facilitate early identification of patients at risk for treatment refractory epilepsy syndromes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaneurol.2026.0204","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:00:36Z","timestamp":1773068436000},"page":"359","source":"Crossref","is-referenced-by-count":3,"title":["Suicidality at Epilepsy Diagnosis and Future Treatment Resistance in Adults With Focal Epilepsy"],"prefix":"10.1001","volume":"83","author":[{"given":"Sarah N.","family":"Barnard","sequence":"first","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia"},{"name":"Alfred Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"French","sequence":"additional","affiliation":[{"name":"Grossman School of Medicine, New York University, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Holmes","sequence":"additional","affiliation":[{"name":"Westchester Medical Center Health Network, New York Medical College, Valhalla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Hegde","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamada Hamid","family":"Altalib","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine, West Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melodie","family":"Winawer","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sperling","sequence":"additional","affiliation":[{"name":"Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Jette","sequence":"additional","affiliation":[{"name":"University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omotola","family":"Hope","sequence":"additional","affiliation":[{"name":"Houston Methodist Sugarland Neurology Associates, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"Nadkarni","sequence":"additional","affiliation":[{"name":"Grossman School of Medicine, New York University, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia"},{"name":"Alfred Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Kuzniecky","sequence":"additional","affiliation":[{"name":"Northwell Health, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lowenstein","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres M.","family":"Kanner","sequence":"additional","affiliation":[{"name":"Miller School of Medicine, University of Miami, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Human Epilepsy Project Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Boro","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Cole","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Gidal","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassel","family":"Abou-Khalil","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandy","family":"Fureman","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Alldredge","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Neuray","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Szabo","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Morrison","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Hesdorffer","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ficker","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gloss","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Dlugos","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Faught","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Schmid","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Geller","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Somerville","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Trinka","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Cutter","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Jackson","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Cascino","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Krauss","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Worrell","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath","family":"Pardoe","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cloyd","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Szaflarski","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hixson","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pollard","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Halford","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon","family":"Kang","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Burneo","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Weisenberg","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Detyniecki","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimford","family":"Meador","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Park","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Marcuse","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Lin","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Brandon","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Fields","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangala","family":"Nadkarni","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Kirschner","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bebin","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orrin","family":"Devinsky","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Penovich","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kwan","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Atkinson","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Klein","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Widdess-Walsh","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani","family":"Singh","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeta","family":"K\u00e4lvi\u00e4inen","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Knowlton","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Mintzer","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl","family":"Haut","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Glynn","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Herman","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Glauser","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Ting","sequence":"additional","affiliation":[{"name":"for the Human Epilepsy Project Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"noi260006r1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies.","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"issue":"9","key":"noi260006r2","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2589","article-title":"The burden of epilepsy and unmet need in people with focal seizures.","volume":"12","author":"Ioannou","year":"2022","journal-title":"Brain Behav"},{"issue":"2","key":"noi260006r3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000503831","article-title":"The epidemiology of epilepsy.","volume":"54","author":"Beghi","year":"2020","journal-title":"Neuroepidemiology"},{"issue":"8","key":"noi260006r4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S1474-4422(23)00151-5","article-title":"Drug resistance in epilepsy.","volume":"22","author":"Perucca","year":"2023","journal-title":"Lancet Neurol"},{"issue":"2","key":"noi260006r5","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1212\/CPJ.0000000000000874","article-title":"Psychiatric comorbidities in people with epilepsy.","volume":"11","author":"Mula","year":"2021","journal-title":"Neurol Clin Pract"},{"issue":"5","key":"noi260006r6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1212\/CPJ.0000000000001114","article-title":"Association between psychiatric comorbidities and mortality in epilepsy.","volume":"11","author":"Tao","year":"2021","journal-title":"Neurol Clin Pract"},{"issue":"9905","key":"noi260006r7","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/S0140-6736(13)60899-5","article-title":"Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study.","volume":"382","author":"Fazel","year":"2013","journal-title":"Lancet"},{"key":"noi260006r8","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.yebeh.2003.08.019","article-title":"Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy.","volume":"4","author":"Jones","year":"2003","journal-title":"Epilepsy Behav"},{"issue":"1","key":"noi260006r9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/epi.13604","article-title":"The burden of premature mortality of epilepsy in high-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy.","volume":"58","author":"Thurman","year":"2017","journal-title":"Epilepsia"},{"issue":"4","key":"noi260006r10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(18)30454-X","article-title":"Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"18","author":"Beghi","year":"2019","journal-title":"Lancet Neurol"},{"issue":"1","key":"noi260006r11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0920-1211(90)90010-S","article-title":"An incident case-referent study of epileptic seizures in adults.","volume":"6","author":"Forsgren","year":"1990","journal-title":"Epilepsy Res"},{"issue":"1-3","key":"noi260006r12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0165-0327(02)00061-7","article-title":"On the increased risk of developing late-onset epilepsy for patients with major affective disorder.","volume":"76","author":"Nilsson","year":"2003","journal-title":"J Affect Disord"},{"issue":"2","key":"noi260006r13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/1531-8249(200002)47:2<246::AID-ANA17>3.0.CO;2-E","article-title":"Major depression is a risk factor for seizures in older adults.","volume":"47","author":"Hesdorffer","year":"2000","journal-title":"Ann Neurol"},{"issue":"1","key":"noi260006r14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/ana.20685","article-title":"Depression and suicide attempt as risk factors for incident unprovoked seizures.","volume":"59","author":"Hesdorffer","year":"2006","journal-title":"Ann Neurol"},{"issue":"8","key":"noi260006r15","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1212\/WNL.58.8_suppl_5.S27","article-title":"Depression and epilepsy: how closely related are they?","volume":"58","author":"Kanner","year":"2002","journal-title":"Neurology"},{"issue":"6","key":"noi260006r16","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/j.1528-1167.2012.03488.x","article-title":"Depressive and anxiety disorders in epilepsy: do they differ in their potential to worsen common antiepileptic drug-related adverse events?","volume":"53","author":"Kanner","year":"2012","journal-title":"Epilepsia"},{"key":"noi260006r17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.seizure.2017.04.007","article-title":"Psychiatric comorbidities in new onset epilepsy: should they be always investigated?","volume":"49","author":"Kanner","year":"2017","journal-title":"Seizure"},{"issue":"2-3","key":"noi260006r18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.eplepsyres.2007.06.003","article-title":"Predictors of pharmacoresistant epilepsy.","volume":"75","author":"Hitiris","year":"2007","journal-title":"Epilepsy Res"},{"issue":"7","key":"noi260006r19","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/epi.13781","article-title":"Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE.","volume":"58","author":"Nogueira","year":"2017","journal-title":"Epilepsia"},{"key":"noi260006r20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.seizure.2022.10.019","article-title":"Psychiatric symptoms predict drug-resistant epilepsy in newly treated patients.","volume":"103","author":"Zhong","year":"2022","journal-title":"Seizure"},{"key":"noi260006r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108243","article-title":"Individuals who develop drug-resistant epilepsy within a year after initial diagnosis have higher burden of mental and physical diseases 1-year prior to epilepsy diagnosis as compared to those whose seizures were controlled during the same interval.","volume":"123","author":"Teneralli","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"11","key":"noi260006r22","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1212\/WNL.0b013e3181f25b16","article-title":"Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients.","volume":"75","author":"Petrovski","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"noi260006r23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.9740\/mhc.2015.01.008","article-title":"Pharmacokinetic characteristics of antiepileptic drugs (AEDs).","volume":"6","author":"Marvanova","year":"2016","journal-title":"Ment Health Clin"},{"issue":"7","key":"noi260006r24","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209821","article-title":"The adverse effects of commonly prescribed antiseizure medications in adults with newly diagnosed focal epilepsy.","volume":"103","author":"Barnard","year":"2024","journal-title":"Neurology"},{"issue":"11","key":"noi260006r25","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1111\/j.1528-1167.2007.01246.x","article-title":"Early postnatal stress confers enduring vulnerability to limbic epileptogenesis.","volume":"48","author":"Salzberg","year":"2007","journal-title":"Epilepsia"},{"issue":"7","key":"noi260006r26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.psyneuen.2007.05.011","article-title":"The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors.","volume":"32","author":"Kumar","year":"2007","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"noi260006r27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1001\/jamaneurol.2016.5042","article-title":"Association of depression and treated depression with epilepsy and seizure outcomes: a multicohort analysis.","volume":"74","author":"Josephson","year":"2017","journal-title":"JAMA Neurol"},{"issue":"9","key":"noi260006r28","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1212\/01.wnl.0000343850.85763.9c","article-title":"A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy.","volume":"72","author":"Kanner","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"noi260006r30","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1111\/epi.16707","article-title":"Focal nonmotor vs motor seizures: the impact on diagnostic delay in focal epilepsy.","volume":"61","author":"Pellinen","year":"2020","journal-title":"Epilepsia"},{"issue":"3","key":"noi260006r31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4088\/JCP.09m05305whi","article-title":"Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID).","volume":"71","author":"Sheehan","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"noi260006r32","first-page":"22","article-title":"The Mini International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"noi260006r33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0924-9338(97)83297-X","article-title":"The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability.","volume":"12","author":"Sheehan","year":"1997","journal-title":"Eur Psychiatry"},{"issue":"12","key":"noi260006r34","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from 3 multisite studies with adolescents and adults.","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"3","key":"noi260006r35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1017\/S003329171900391X","article-title":"Characterizing the phenomenology of passive suicidal ideation: a systematic review and meta-analysis of its prevalence, psychiatric comorbidity, correlates, and comparisons with active suicidal ideation.","volume":"50","author":"Liu","year":"2020","journal-title":"Psychol Med"},{"issue":"11","key":"noi260006r36","doi-asserted-by":"publisher","first-page":"e1123","DOI":"10.1212\/WNL.0000000000201671","article-title":"Mood and anxiety disorders and suicidality in patients with newly diagnosed focal epilepsy: an analysis of a complex comorbidity.","volume":"100","author":"Kanner","year":"2023","journal-title":"Neurology"},{"issue":"6","key":"noi260006r37","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug-resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"10","key":"noi260006r38","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/jamaneurol.2025.2949","article-title":"Treatment response to antiseizure medications in people with newly diagnosed focal epilepsy.","volume":"82","author":"Barnard","year":"2025","journal-title":"JAMA Neurol"},{"key":"noi260006r39","doi-asserted-by":"publisher","DOI":"10.3389\/fnint.2022.898547","article-title":"Suicidality in patients with epilepsy: why should neurologists care?","volume":"16","author":"Kanner","year":"2022","journal-title":"Front Integr Neurosci"},{"issue":"2","key":"noi260006r40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2147\/NDT.S2158","article-title":"Epilepsy and suicide: pathogenesis, risk factors, and prevention.","volume":"4","author":"Verrotti","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"noi260006r41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.physbeh.2016.05.015","article-title":"Hypothalamic-pituitary-adrenocortical axis dysfunction in epilepsy.","volume":"166","author":"Wulsin","year":"2016","journal-title":"Physiol Behav"},{"key":"noi260006r42","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135618","article-title":"Hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy.","volume":"746","author":"Basu","year":"2021","journal-title":"Neurosci Lett"},{"issue":"2","key":"noi260006r43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3988\/jcn.2023.0308","article-title":"Hypothalamic-pituitary-adrenal axis and epilepsy.","volume":"20","author":"Bian","year":"2024","journal-title":"J Clin Neurol"},{"issue":"6","key":"noi260006r44","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.bbi.2008.03.009","article-title":"The role of cytokines in the pathophysiology of epilepsy.","volume":"22","author":"Vezzani","year":"2008","journal-title":"Brain Behav Immun"},{"issue":"5","key":"noi260006r45","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1526-4610.2012.02117.x","article-title":"Migraine headaches and suicide attempt.","volume":"52","author":"Breslau","year":"2012","journal-title":"Headache"},{"issue":"2","key":"noi260006r46","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1212\/WNL.42.2.392","article-title":"Migraine, suicidal ideation, and suicide attempts.","volume":"42","author":"Breslau","year":"1992","journal-title":"Neurology"},{"issue":"3","key":"noi260006r47","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jamaneurol.2024.4974","article-title":"Risk of attempted and completed suicide in persons diagnosed with headache.","volume":"82","author":"Elser","year":"2025","journal-title":"JAMA Neurol"},{"issue":"1","key":"noi260006r48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/jamaneurol.2024.3976","article-title":"Psychiatric comorbidities in persons with epilepsy compared with persons without epilepsy: a systematic review and meta-analysis.","volume":"82","author":"Kwon","year":"2025","journal-title":"JAMA Neurol"},{"issue":"6","key":"noi260006r49","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1212\/WNL.0b013e31827b1ae0","article-title":"Depression in epilepsy: a systematic review and meta-analysis.","volume":"80","author":"Fiest","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"noi260006r50","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/epi.13769","article-title":"Anxiety and depressive disorders in people with epilepsy: a meta-analysis.","volume":"58","author":"Scott","year":"2017","journal-title":"Epilepsia"},{"issue":"8","key":"noi260006r51","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/ijerph16081451","article-title":"A meta-analysis of the rates of suicide ideation, attempts and deaths in people with epilepsy.","volume":"16","author":"Abraham","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"noi260006r52","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/da.20674","article-title":"The relationship between anxiety disorders and suicide attempts: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"27","author":"Nepon","year":"2010","journal-title":"Depress Anxiety"},{"issue":"3","key":"noi260006r53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/070674371405900303","article-title":"Suicidal behavior in mood disorders\u2014who, when, and why?","volume":"59","author":"Isomets\u00e4","year":"2014","journal-title":"Can J Psychiatry"},{"key":"noi260006r54","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.yebeh.2014.05.011","article-title":"The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy.","volume":"36","author":"Ettinger","year":"2014","journal-title":"Epilepsy Behav"},{"key":"noi260006r55","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.yebeh.2018.12.006","article-title":"Optimal cutoff score of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) for detecting major depressive disorder: a meta-analysis.","volume":"92","author":"Kim","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"10","key":"noi260006r56","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7.","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"noi260006r29","unstructured":"The Human Epilepsy Project. Home page. Accessed October 20, 2023. http:\/\/www.humanepilepsyproject.org"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2845901\/jamaneurology_barnard_2026_oi_260006_1774545309.23342.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:00:19Z","timestamp":1776092419000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2845901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2026.0204","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}